Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features.

[1]  E. Tan,et al.  Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A. , 1981, Clinical and experimental immunology.

[2]  B. S. Andrews,et al.  Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes. , 1980, Annals of internal medicine.

[3]  D. Koffler.  Systemic lupus erythematosus. , 1980, Scientific American.

[4]  S. Sherlock,et al.  Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis. , 1979, The New England journal of medicine.

[5]  M. Meurer,et al.  Circulating immune complexes in active Behçet's disease. , 1978, Clinical and experimental immunology.

[6]  E. Dickson,et al.  The composition of the isolated soluble immune complexes in primary biliary cirrhosis (PBC) , 1978 .

[7]  E. Dickson,et al.  Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years. , 1978, Clinical and experimental immunology.

[8]  R. Gupta,et al.  Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. , 1978, Immunology.

[9]  K. Isselbacher,et al.  Circulating immune complexes and complement activation in primary biliary cirrhosis. , 1978, The New England journal of medicine.

[10]  D. Jewell,et al.  Immune complexes in acute and chronic liver disease. , 1978, Clinical and experimental immunology.

[11]  R. Gupta,et al.  Pulmonary and extrapulmonary sarcoidosis in relation to circulating immune complexes: a quantification of immune complexes by two radioimmunoassays. , 1977, The American review of respiratory disease.

[12]  E. Elias,et al.  Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. , 1976, The Journal of laboratory and clinical medicine.

[13]  K. Isselbacher,et al.  Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes. , 1975, Gastroenterology.

[14]  I. Jaffe.  PENICILLAMINE TREATMENT OF RHEUMATOID ARTHRITIS: EFFECT ON IMMUNE COMPLEXES , 1975, Annals of the New York Academy of Sciences.

[15]  K. Isselbacher,et al.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. , 1975, The Journal of clinical investigation.

[16]  S. Ruddy,et al.  HUMAN COMPLEMENT METABOLISM: AN ANALYSIS OF 144 STUDIES1 , 1975 .

[17]  S. Sherlock,et al.  The presentation and diagnosis of 100 patients with primary biliary cirrhosis. , 1973, The New England journal of medicine.

[18]  S. Lamm,et al.  Lead content of milks fed to infants--1971-1972. , 1973, The New England journal of medicine.

[19]  E. Gjone,et al.  Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system. , 1973, Clinical and experimental immunology.

[20]  L. Elveback,et al.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. , 1972, Gastroenterology.

[21]  R. N. Macsween,et al.  Serum protein levels in primary biliary cirrhosis , 1972, Journal of clinical pathology.

[22]  R. Peters,et al.  Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome. , 1971, The American journal of medicine.

[23]  S. Sherlock,et al.  Impaired delayed hypersensitivity in primary biliary cirrhosis. , 1969, Lancet.

[24]  H. Müller-Eberhard,et al.  Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults. , 1967, Journal of immunology.

[25]  E. Tan.  Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus. , 1967, The Journal of laboratory and clinical medicine.

[26]  P. Schur,et al.  Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. , 1966, The Journal of clinical investigation.

[27]  J. G. Walker,et al.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. , 1966, Clinical and experimental immunology.

[28]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.

[29]  R. Bahn,et al.  THE PATHOLOGY OF PRIMARY BILIARY CIRRHOSIS WITH EMPHASIS ON HISTOGENESIS. , 1964, American journal of clinical pathology.

[30]  J. Vaughan,et al.  Use of Anti-Rh Sera for Demonstrating Agglutination Activating Factor in Rheumatoid Arthritis.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[31]  A. Theofilopoulos,et al.  The biology and detection of immune complexes. , 1979, Advances in immunology.

[32]  M. Frank,et al.  Primary Biliary Cirrhosis and the Complement System , 1979 .

[33]  R. Gupta,et al.  Circulating immune complexes in systemic lupus erythematosus. Association with other immunologic abnormalities but not with changes in renal function. , 1978, The Journal of rheumatology.

[34]  A. Theofilopoulos,et al.  The Raji cell radioimmune assay for detecting immune complexes in human sera. , 1976, The Journal of clinical investigation.

[35]  H. Colten.  Biosynthesis of complement. , 1976, Advances in immunology.